TOPU
Trustees of Princeton University Portfolio holdings
AUM
$7.77M
This Quarter Return
+20.17%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$66.9M
AUM Growth
+$66.9M
(-11%)
Cap. Flow
-$19.3M
Cap. Flow
% of AUM
-28.92%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
3
Increased
–
Reduced
1
Closed
4
Top Buys
| 1 |
Adverum Biotechnologies
ADVM
|
$808K |
| 2 |
Intuit
INTU
|
$769K |
| 3 |
Ocular Therapeutix
OCUL
|
$629K |
Top Sells
| 1 |
DocuSign
DOCU
|
$12.1M |
| 2 |
TransDigm Group
TDG
|
$5.07M |
| 3 |
Revolution Medicines
RVMD
|
$3.16M |
| 4 |
CRISPR Therapeutics
CRSP
|
$1.03M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$230K |
Sector Composition
| 1 | Real Estate | 82.26% |
| 2 | Industrials | 14.44% |
| 3 | Healthcare | 2.15% |
| 4 | Technology | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBGS
1
JBG SMITH
JBGS
$1.32B
| $55M | 82.26% |
1,759,817
| – | – |
|
|
2
TransDigm Group
TDG
$78.8B
| $9.66M | 14.44% |
15,607
-8,200
| -34% | -$5.07M |
|
|
3
Adverum Biotechnologies
ADVM
$64.6M
| $808K | 1.21% |
+74,530
| New | +$808K |
|
|
4
Intuit
INTU
$186B
| $769K | 1.15% |
+2,025
| New | +$769K |
|
|
5
Ocular Therapeutix
OCUL
$2.12B
| $629K | 0.94% |
+30,410
| New | +$629K |
|
|
6
CRISPR Therapeutics
CRSP
$4.71B
| – | – |
-12,312
| Closed | -$1.03M |
|
|
7
DocuSign
DOCU
$15.5B
| – | – |
-56,021
| Closed | -$12.1M |
|
|
8
Revolution Medicines
RVMD
$7.1B
| – | – |
-90,758
| Closed | -$3.16M |
|
|
ISEE
9
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-40,705
| Closed | -$230K |
|